×
App Icon
The Standard e-Paper
Home To Bold Columnists
★★★★ - on Play Store
Download Now

FDA warns about counterfeit versions of diabetes drug Ozempic

Vocalize Pre-Player Loader

Audio By Vocalize

A pharmacist displays boxes of Ozempic, a drug used for treating type 2 diabetes and obesity made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. [Reuters]

The U.S. Food and Drug Administration on Thursday warned consumers not to use counterfeit versions of Novo Nordisk's diabetes drug Ozempic that have been found in the country's drug supply chain.

The health regulator said that it would continue to investigate counterfeit Ozempic 1-milligram injections and had seized thousands of units, but that some might still be available for purchase.

Premium Article

Get Full Access for Ksh299/Week.

Bold Reporting Takes Time, Courage and Investment. Stand With Us.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
By AFP 1 hr ago
Sports
Kenyan double-double as Korir, Lokedi defend Boston Marathon crowns
Sports
Olympic champion Gabby Thomas to headline sprints at Kip Keino Classic
Sports
Why Kenya has struggled to produce world class talent outside athletics
Sports
Pipeline and KCB Bank to renew rivalry in continental tourney semis